Oncothyreon Announces Appointments to Board of Directors

BELLEVUE, WA, June 9 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) (the "Company") today announced that Daniel K. Spiegelman and Stephen K. Burley, M.D., D.Phil. have joined its board of directors for three-year terms. The Company also announced the retirement of S. Robert Blair from the board of directors.
MORE ON THIS TOPIC